Tech Company Financing Transactions
Diasome Pharmaceuticals Funding Round
Diasome Pharmaceuticals, based in Cleveland, secured $4.4 million in investment from private investors.
Transaction Overview
Company Name
Announced On
1/18/2017
Transaction Type
Debt
Amount
$4,350,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 4 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10000 Cedar Ave. 6
Cleveland, OH 44106
USA
Cleveland, OH 44106
USA
Phone
Website
Email Address
Overview
Diasome Pharmaceuticals, Inc. is a venture-backed biopharmaceutical company focused on novel insulin-based therapies for the improved treatment of diabetes. The Company was formed in 2004 and has completed multiple Phase II human studies of HDV-Insulin, its proprietary insulin targeting system.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Geho
Chief Financial Officer
Helga Kautsky
Chief Scientific Officer
Blair Geho
Browse more venture capital transactions:
Prev: 1/18/2017: Hypori venture capital transaction
Next: 1/18/2017: AppsFlyer venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs